2026 Myeloma Treatment Guidelines of the Turkish Myeloma Study Group.

Beksac M, Mastanzade M, Degirmenci BB, Oluk B, Saglam B, Ozluk DO, Cengiz E, Alhan FN, Dikici HZ, Uygun KY, Tıglıoglu M, Yeniay MK, Ozgeyik MO, Kosemehmetoglu OS, Ozkan SG, Kars TU, Salihoglu A, Seval GC

Open source

DOI: 10.1016/j.clml.2026.08.008
Published: 2026 Aug 15
Container: Clinical lymphoma, myeloma & leukemia
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.clml.2026.08.008,
  title = {2026 Myeloma Treatment Guidelines of the Turkish Myeloma Study Group.},
  author = {Beksac M and Mastanzade M and Degirmenci BB and Oluk B and Saglam B and Ozluk DO and Cengiz E and Alhan FN and Dikici HZ and Uygun KY and Tıglıoglu M and Yeniay MK and Ozgeyik MO and Kosemehmetoglu OS and Ozkan SG and Kars TU and Salihoglu A and Seval GC},
  year = {2026},
  journal = {Clinical lymphoma, myeloma \& leukemia},
  doi = {10.1016/j.clml.2026.08.008},
  url = {https://doi.org/10.1016/j.clml.2026.08.008}
}

RIS

TY  - JOUR
TI  - 2026 Myeloma Treatment Guidelines of the Turkish Myeloma Study Group.
AU  - Beksac M
AU  - Mastanzade M
AU  - Degirmenci BB
AU  - Oluk B
AU  - Saglam B
AU  - Ozluk DO
AU  - Cengiz E
AU  - Alhan FN
AU  - Dikici HZ
AU  - Uygun KY
AU  - Tıglıoglu M
AU  - Yeniay MK
AU  - Ozgeyik MO
AU  - Kosemehmetoglu OS
AU  - Ozkan SG
AU  - Kars TU
AU  - Salihoglu A
AU  - Seval GC
PY  - 2026
JO  - Clinical lymphoma, myeloma & leukemia
DO  - 10.1016/j.clml.2026.08.008
UR  - https://doi.org/10.1016/j.clml.2026.08.008
ER  -

APA

M, B., M, M., BB, D., B, O., B, S., DO, O., E, C., FN, A., HZ, D., KY, U., M, T., MK, Y., MO, O., OS, K., SG, O., TU, K., A, S., & GC, S. (2026). 2026 Myeloma Treatment Guidelines of the Turkish Myeloma Study Group.. Clinical lymphoma, myeloma & leukemia. https://doi.org/10.1016/j.clml.2026.08.008

Source records

pubmed · retrieved 2026-09-25T20:39:13.777Z